Trial Profile
Losartan/Hydrochlorothiazide Excels High-dose Angiotensin Receptor Blockers in Lowering Morning Home Blood Pressure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Aug 2013
Price :
$35
*
At a glance
- Drugs Losartan/hydrochlorothiazide (Primary) ; Angiotensin receptor antagonists; Candesartan cilexetil; Irbesartan; Losartan; Olmesartan medoxomil; Telmisartan; Valsartan
- Indications Essential hypertension
- Focus Therapeutic Use
- 12 Jan 2011 New trial record